HCPCS code Q5151 — Inj, eculizumab-aagh, 2 mg. Status: Active. Effective Apr 1, 2025. Source: CMS HCPCS Level II.

Q5151

Active

Inj, eculizumab-aagh, 2 mg

Injection, eculizumab-aagh (epysqli), biosimilar, 2 mg

Category: Temporary
Section: Q-codes: Temporary Codes
Effective: Apr 1, 2025
Code type: alphanumeric
OPPS Status: G — Pass-through drugs and biologicals
OPPS APC: 0852

MUE — Medically Unlikely Edits

Maximum units of Q5151 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
DME Supplier 600
Outpatient Hospital 600
Practitioner Services 600

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
51759-0208-13 Epysqli

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2025-Q2
    Inj, eculizumab-aagh, 2 mg